: To maintain the illusion of success, Theranos used commercial blood analyzers from third parties (like Siemens) and diluted tiny samples to run them, which led to dangerously inaccurate results for patients.
: Key former employees, such as Tyler Shultz and Erika Cheung , risked their careers and legal retaliation to help Carreyrou expose the company's malpractices. : To maintain the illusion of success, Theranos
: Carreyrou, an investigative reporter for The Wall Street Journal , broke the story in late 2015. His reporting relied on interviews with over 150 people, including 60 former employees, despite aggressive legal threats from Theranos. Key Themes and Red Flags His reporting relied on interviews with over 150
John Carreyrou’s Bad Blood: Secrets and Lies in a Silicon Valley Startup is an investigative report that chronicles the rise and fall of , a multibillion-dollar biotech company built on fraudulent claims. The book details how founder Elizabeth Holmes deceived investors, partners, and patients by claiming to have revolutionized blood testing with a device that never actually worked. Core Narrative and Investigation Core Narrative and Investigation : Holmes, a 19-year-old
: Holmes, a 19-year-old Stanford dropout, founded Theranos in 2003 with the promise that hundreds of medical tests could be performed using just a few drops of blood from a finger prick.